CERVINO

A Phase 3, Multicenter, Randomized, Open Label Study of Etentamig Compared With Standard Available Therapies in Subjects With Relapsed or Refractory Multiple Myeloma (3L+ RRMM Monotherapy Study)

Near Add Your Location

Sorting 43 by

University of Cincinnati College of Medicine
George L. Strike Bone Marrow Transplant Program
Cincinnati, OH
  • Accepting patients
Northwest Medical Specialties (Tacoma)
NWMS Tacoma — Medical Oncology & Infectious Diseases
Tacoma, WA
  • Accepting patients
Cleveland Clinic - Taussig Cancer Center
Taussig Cancer Institute
Cleveland, OH
  • Accepting patients
American Oncology Partners of Maryland (Bethesda)
The Center for Cancer & Blood Disorders - Bethesda
Bethesda, MD
  • Accepting patients
Oncology Consultants PA
Houston, TX
  • Accepting patients
Duke Cancer Center
Duke University Medical Center
Durham, NC
  • Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 788-8038

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.